Litcius/Paper detail

HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis

Guillermo Villacampa, Tomás Pascual, Paolo Tarantino, Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac, PierFranco Conte, Mario Mancino, Valentina Guarneri, Maria Vittoria Dieci, Adrienne G. Waks, Francesco Schettini, Fara Brasó‐Maristany, Gaia Griguolo, Beatriz Alonso de Castro, Cristina Reboredo, Silvia Antolín, Coralia Bueno, Isabel Echavarría, Sara López‐Tarruella, Tatiana Massarrah, Marı́a del Monte-Millán, Miguel Martı́n, Wesley Buckingham, Joel S. Parker, Ana Vivancos, Kornélia Polyák, Otto Metzger, Antonio C. Wolff, Angela DeMichele, Nadine Tung, Charles M. Perou, Laia Paré, Patricia Villagrasa, Aleix Prat, Sara M. Tolaney

2025The Lancet Oncology17 citationsDOI

Topics & Concepts

Meta-analysisBreast cancerStage (stratigraphy)OncologyMedicineInternal medicineCancerBiologyPaleontologyHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies